Hasil Pencarian - Abhya Gupta
- Menampilkan 1 - 8 hasil dari 8
-
1
-
2
-
3
-
4
An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic f... oleh Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac
Diterbitkan 2020-12-01
Artikel -
5
FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD oleh James Crapo, Abhya Gupta, Robert M Mroz, Andrea Ludwig-Sengpiel, Markus Beck, Bérengère Langellier, Carina Ittrich, Frank Risse
Diterbitkan 2021-03-01
Artikel -
6
Anticipated responses to a hypothetical minimum price for cigarettes and roll-your-own tobacco: an online cross-sectional survey with cigarette smokers and ex-smokers in the UK oleh James Crapo, Abhya Gupta, Robert M Mroz, Andrea Ludwig-Sengpiel, Markus Beck, Bérengère Langellier, Carina Ittrich, Frank Risse
Diterbitkan 2021-03-01
Artikel -
7
Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study oleh James D. Crapo, Abhya Gupta, David A. Lynch, Alice M. Turner, Robert M. Mroz, Wim Janssens, Andrea Ludwig-Sengpiel, Harald Koegler, Anastasia Eleftheraki, Frank Risse, Claudia Diefenbach
Diterbitkan 2023-11-01
Artikel -
8
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf oleh James D. Chalmers, Abhya Gupta, Sanjay H. Chotirmall, April Armstrong, Peter Eickholz, Naoki Hasegawa, Pamela J. McShane, Anne E. O'Donnell, Michal Shteinberg, Henrik Watz, Anastasia Eleftheraki, Claudia Diefenbach, Wiebke Sauter
Diterbitkan 2023-06-01
Artikel